Drug intelligence / Profile preview

VLA1555

Development stage
Unknown
Lead developer
Instituto Butantan
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

VLA1555 is a single-shot, live-attenuated chikungunya virus (CHIKV) vaccine candidate developed by Instituto Butantan in collaboration with Valneva SE. It is a technology transfer of Valneva's approved vaccine VLA1553 (brand name IXCHIQ®), specifically adapted for local lyophilization and packaging by Butantan for use in Brazil and other Latin American or low- and middle-income countries (LMICs). The vaccine works by eliciting a protective immune response against the chikungunya virus through the administration of a live-attenuated strain. It is currently under regulatory review by Brazil's ANVISA and is being evaluated in Phase 3b clinical trials, including studies on co-administration with the Butantan live-attenuated dengue vaccine (Butantan-DV).

Other names
Butantan chikungunya vaccine
02

Targets

MXRA8 (Matrix remodeling-associated protein 8)

Beyond the preview

Go deeper on VLA1555.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VLA1555.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call